Neoplasms, Colorectal Not Yet Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03843853Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal CancerTreatment